Matinas BioPharma Holdings Inc (MTNB) Stock Price, Quote, News & History

MTNBAMEX
$0.1600
-0.032-16.67%
At close: Sep 15, 5:00 PM EST

Matinas BioPharma Hldgs (MTNB) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-6.42M
Investing Cash Flow (TTM)
335.00K
Financing Cash Flow (TTM)
121.00K
Free Cash Flow (TTM)
-6.42M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-5.96M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.60M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.31
Earnings Yield % (TTM)
-718.75%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.12

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$8.00K
Total Cash
$761.00K
Debt to Equity
0.00
Issuance of Debt (TTM)
-$8.00K
Repayment of Debt (TTM)
-$8.00K

Key Statistics

Open
$0.19
Close
$0.16
Volume / Avg.
1.39M / 5.54M
Day Range
$0.15 - $0.19
52 Wk Range
0.15 - 2.14
Market Cap
$2.35M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
29
Short Interest
2.12%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracell...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Matinas BioPharma Hldgs (MTNB) stock?

A

You can purchase shares of Matinas BioPharma Hldgs (AMEX:MTNB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Matinas BioPharma Hldgs (MTNB) competitors?

Q

What is the forecast, or price target, for Matinas BioPharma Hldgs (MTNB) stock?

A

Matinas BioPharma Hldgs has a consensus price target of $150.00.

Q

What is the current price for Matinas BioPharma Hldgs (MTNB)?

A

The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $ last updated .

Q

Does Matinas BioPharma Hldgs (MTNB) pay a dividend?

A

There are no upcoming dividends for Matinas BioPharma Hldgs.

Q

When is Matinas BioPharma Hldgs (AMEX:MTNB) reporting earnings?

A

Matinas BioPharma Hldgs does not have any upcoming earnings scheduled.

Q

Is Matinas BioPharma Hldgs (MTNB) going to split?

A

There is no upcoming split for Matinas BioPharma Hldgs.

Q

What sector and industry does Matinas BioPharma Hldgs (MTNB) operate in?

A

Matinas BioPharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.